Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10781015rdf:typepubmed:Citationlld:pubmed
pubmed-article:10781015lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0205042lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0019409lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0035028lld:lifeskim
pubmed-article:10781015lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:10781015pubmed:issue1lld:pubmed
pubmed-article:10781015pubmed:dateCreated2000-6-27lld:pubmed
pubmed-article:10781015pubmed:abstractText1. Mechanisms of protease-activated receptor-1 (PAR1)- and PAR2-induced relaxation were investigated in pre-contracted porcine coronary artery ring preparations. 2. Thrombin (0.01 - 0.3 u ml(-1)) and the PAR1-activating peptide SFLLRN (0.1 - 10 microM) caused concentration- and endothelium-dependent relaxation. pEC(50)s (-log u ml(-1) for enzymes, -log M for peptides) and maximum relaxations (R(max), %) for thrombin were 1.8+/-0.1 and 93.5+/-2.8% respectively, and for SFLLRN 6.8+/-0.1 and 90.8+/-1.3%. Similar concentration- and endothelium-dependent relaxations occurred with trypsin (pEC(50) 2.3+/-0.2; R(max) 94.1+/-1.9%) and the PAR2-activating peptide SLIGRL (pEC(50) 6.5+/-0.2; R(max) 92.4+/-1.6%). 3. Relaxations to thrombin, SFLLRN, trypsin and SLIGRL were significantly inhibited (P<0.05) to similar extents by the nitric oxide (NO) synthase inhibitor N(G)-nitro-L-arginine (L-NOARG; 100 microM) and the NO scavenger oxyhaemoglobin (20 microM), both separately and in combination. 4. In the presence of the L-type voltage-operated calcium channel (L-VOCC) inhibitor nifedipine (0.3 microM), K(+) (67 mM) abolished the L-NOARG-resistant relaxations to thrombin, SFLLRN, trypsin and SLIGRL. However, nifedipine alone significantly (P<0.05) reduced the pEC(50) (1.5+/-0.1) and R(max) (77.5+/-7.0%) for thrombin but had no effect on relaxations to SFLLRN, trypsin or SLIGRL. Furthermore, L-NOARG-resistant relaxations to thrombin were abolished by nifedipine, whereas relaxations to SFLLRN, trypsin or SLIGRL were not further inhibited by combined treatment with nifedipine and L-NOARG, than they were with L-NOARG treatment alone. 5. Similar selective inhibition of the L-NOARG-resistant relaxation to thrombin, but not SFLLRN, occurred with verapamil (1 microM) and diltiazem (3 microM). 6. Our results suggest heterogeneous mechanisms in the NO-independent relaxation to thrombin and peptide activators of PAR1 in the porcine coronary artery.lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:languageenglld:pubmed
pubmed-article:10781015pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:citationSubsetIMlld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10781015pubmed:statusMEDLINElld:pubmed
pubmed-article:10781015pubmed:monthMaylld:pubmed
pubmed-article:10781015pubmed:issn0007-1188lld:pubmed
pubmed-article:10781015pubmed:authorpubmed-author:HamiltonJ RJRlld:pubmed
pubmed-article:10781015pubmed:authorpubmed-author:CocksT MTMlld:pubmed
pubmed-article:10781015pubmed:issnTypePrintlld:pubmed
pubmed-article:10781015pubmed:volume130lld:pubmed
pubmed-article:10781015pubmed:ownerNLMlld:pubmed
pubmed-article:10781015pubmed:authorsCompleteYlld:pubmed
pubmed-article:10781015pubmed:pagination181-8lld:pubmed
pubmed-article:10781015pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:meshHeadingpubmed-meshheading:10781015...lld:pubmed
pubmed-article:10781015pubmed:year2000lld:pubmed
pubmed-article:10781015pubmed:articleTitleHeterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery.lld:pubmed
pubmed-article:10781015pubmed:affiliationDepartment of Pharmacology, University of Melbourne, Victoria 3010, Australia.lld:pubmed
pubmed-article:10781015pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10781015pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10781015lld:pubmed
More...